Please login to the form below

Not currently logged in
Email:
Password:

Quintiles announces new European HQ

Quintiles has announced that it is re-locating its European headquarters to Reading

Quintiles has announced that it is re-locating its European headquarters to Reading.

The move will bring together employees from each of its four business pillars: clinical, commercial, consulting and capital solutions to support Quintiles' integrated service offering.

It is designed to create an even higher level of collaboration and effectiveness among Quintiles' European team to better serve the company's biopharmaceutical customers.

Dr Dennis Gillings, CBE, Quintiles chairman and CEO, said: "Our customers are facing an increasingly complex set of challenges which we refer to as New Health. To help our customers succeed in this new landscape, we are constantly looking at how we can raise our game around teamwork, customer service and quality – three of our core values.

"This move to a technologically advanced single site will be a big step forward for our highly talented team and the customers they serve."

The five-storey building at Green Park has been designed and built to the highest sustainability standards. In May 2010, the British Council for Offices named 500 Brook Drive the winner of its Commercial Workplace Award and it is shortlisted for the National Award, to be announced in October 2010.

This investment follows the opening of Quintiles state-of-the-art laboratory and office facility in Edinburgh in 2009 and the expansion of its phase I facility in London, completed in March 2010.

Quintiles employs more than 2000 people in the UK and in 2010 was named one of the UK's 50 best workplaces by the Great Place to Work Institute. It is anticipated that the building will be occupied during late 2011.

3rd August 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...

Infographics